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Abstract
Background: Infectious Salmonid Anaemia Virus (ISAV) causes a notifiable disease that poses a large threat for
Atlantic salmon (Salmo salar) aquaculture worldwide. There is no fully effective treatment or vaccine, and therefore
selective breeding to increase resistance to ISAV is a promising avenue for disease prevention. Genomic selection
and potentially genome editing can be applied to enhance host resistance, and these approaches benefit from
improved knowledge of the genetic and functional basis of the target trait. The aim of this study was to
characterise the genetic architecture of resistance to ISAV in a commercial Atlantic salmon population and study its
underlying functional genomic basis using RNA Sequencing.
Results: A total of 2833 Atlantic salmon parr belonging to 194 families were exposed to ISAV in a cohabitation
challenge in which cumulative mortality reached 63% over 55 days. A total of 1353 animals were genotyped using
a 55 K SNP array, and the estimate of heritability for the trait of binary survival was 0.13–0.33 (pedigree-genomic). A
genome-wide association analysis confirmed that resistance to ISAV was a polygenic trait, albeit a genomic region
in chromosome Ssa13 was significantly associated with resistance and explained 3% of the genetic variance. RNA
sequencing of the heart of 16 infected (7 and 14 days post infection) and 8 control fish highlighted 4927 and 2437
differentially expressed genes at 7 and 14 days post infection respectively. The complement and coagulation
pathway was down-regulated in infected fish, while several metabolic pathways were up-regulated. The interferon
pathway showed little evidence of up-regulation at 7 days post infection but was mildly activated at 14 days,
suggesting a potential crosstalk between host and virus. Comparison of the transcriptomic response of fish with
high and low breeding values for resistance highlighted TRIM25 as being up-regulated in resistant fish.
Conclusions: ISAV resistance shows moderate heritability with a polygenic architecture, but a significant QTL was
detected on chromosome 13. A mild up-regulation of the interferon pathway characterises the response to the
virus in heart samples from this population of Atlantic salmon, and candidate genes showing differential expression
between samples with high and low breeding values for resistance were identified.
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Background
The demand for high-quality animal protein for human
diets has increased steadily during the last decades and is
expected to accelerate over the next thirty years, in parallel
to human population growth [1]. When paired with the
challenges of climate change and increased competition
for land use [2], a sustainable increase in farmed animal
protein production efficiency is required to meet the glo-
bal food security challenge [3, 4]. Aquaculture is typically
resource-efficient, with high rates of feed efficiency and
protein retention compared to terrestrial livestock [5], and
is expected to play a major role feeding the world in the
coming years. While aquaculture production has risen
steadily in the recent decades [6], it can also be high-risk,
in part due to infectious diseases, which pose major
threats to entire production systems, with downstream
impacts on efficiency and sustainability.
One such disease threat for farmed Atlantic salmon
(Salmo salar) is infectious salmon anaemia (ISA), caused
by an aquatic orthomyxovirus of the same name (ISAV).
ISAV is an enveloped negative-sense single stranded
RNA virus member of the family Orthomyxoviridae, and
therefore closely related to influenza viruses. Viruses of
this family share similar strategies of infection, using
haemagglutinin activity to enter the cells and fusion ac-
tivity to escape the lysosome, followed by viral RNA rep-
lication in the nucleus of the host cell and modulation of
host immune responses [7–9]. The genome of ISAV is
divided in 8 segments that encode at least 10 different
proteins, and the virus can be divided in two groups, the
low virulence ISAV-HPR0 and the virulent ISAV-HPRΔ,
which has a deletion in the highly polymorphic region of
the haemagglutinin-esterase gene [10]. ISA is classified
as a list II disease by the EU fish health directive and as
a notifiable disease by the World Organisation for Ani-
mal Health [11], which means that entire stocks have to
be culled upon detection of the virus to avoid the spread
to nearby farms. While outbreaks were first detected in
Norway, ISA has been observed in all major salmon pro-
ducing countries [12–18]. Just 2 years after its first de-
tection in Chile in 2007, ISA caused the collapse of the
salmon aquaculture industry of the country, reducing
Atlantic salmon production by ~ 75% in two consecutive
years [19]. The most characteristic clinical sign of the
disease is severe anaemia, often accompanied by lack of
appetite and lethargic behaviour [19]. In production set-
tings, a severe ISA outbreak can cause mortalities of
above 90% [20]. Currently there are no effective treat-
ments against ISAV, and available vaccines are typically
only partially protective [21].
The use of genetic and genomic technologies is be-
coming an integral part of efforts to reduce the fre-
quency and severity of disease outbreaks in aquaculture
species [22]. Genomic selection exploits both between
and within family genetic variation to improve the innate
resistance of aquaculture stocks via selective breeding,
with cumulative benefits every generation [21]. Several
studies have shown that host resistance to ISAV has a
significant additive genetic component in Atlantic sal-
mon, with heritability estimates ranging from 0.13 to
0.40 [23–28]. Furthermore, studies using molecular
markers to investigate the genetic architecture under-
lying this heritability have revealed putative minor QTL
[28–30], and a comparative genomic analysis highlighted
potential underlying genes [31]. Several studies have also
examined the host response to ISAV by profiling gene
expression in tissues and cell lines [32–37]. Generally,
these studies have reported a notable up-regulation of
innate immunity which did not confer complete protec-
tion from the impact of the virus, and which was less
marked in vaccinated or secondary-infected fish. Not-
ably, salmon immune responses to ISAV have been re-
ported to be tissue-dependant and tightly regulated by
viral transcription [37].
Genetic improvement by selective breeding is limited
by the existing additive genetic variation for the trait of
interest in the population, and the ability to efficiently
measure the trait, which limits the accuracy of selection
and therefore genetic gain. The detection of functional
genes and variants controlling disease resistance, as well
as a better understanding of the genomic mechanisms
underpinning disease resistance, can contribute to im-
prove the efficiency of aquaculture breeding pro-
grammes by improvement of genomic selection methods
[22]. Furthermore, this information can feed into gen-
ome editing efforts to enhance disease resistance,
whether it is exploiting existing genetic variation or gen-
erating de novo mutations based on the functional basis
of disease resistance [38, 39]. One route to achieving this
is to integrate transcriptomic data with genetic mapping
data to identifying putative functional genes and path-
ways connected to resistance, and this approach has
been applied for genetic resistance to viral and parasitic
diseases in Atlantic salmon [40, 41].
To assess the potential for selection of ISAV resistance
in a commercial Atlantic salmon population and gain
insight into the functional genetic basis of the trait, a
large scale ISAV disease challenge in 2833 Atlantic sal-
mon parr belonging to 194 families of the SalmoBreed
and StofnFiskur strains was performed. A total of 1353
fish were genotyped for 55 K SNP markers, and RNA se-
quencing was performed on subsets of the challenged
population with divergent breeding values for resistance.
These datasets were then used to: i) evaluate the herit-
ability of resistance to ISAV in a commercial Atlantic
salmon population, ii) assess the genetic architecture of
the trait using a genome-wide association study
(GWAS), and iii) compare the transcriptomic responses
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to infection and if this response varied between resistant
and susceptible animals.
Results
Disease challenge and genetic parameters of ISAV
resistance
The ISAV cohabitation challenge on 2833 fish belonging
to 194 families (15.9 ± 4.5 fish per family) from Bench-
mark Genetics commercial breeding programme showed
substantial variation in mortality rate between families
(Fig. 1a), with values ranging from 7 to 100%, suggesting
the presence of a genetic component underlying resistance
to ISAV in this population. Mortalities began at day 19
and reached 63%, with most mortalities occurring between
day 22 and 28 (Fig. 1b). The pedigree-based heritability for
resistance to ISAV was estimated to be 0.13 ± 0.05.
Genetic architecture of ISAV resistance
A subset of the challenged population (n = 1353; 194 fam-
ilies; 7.0 ± 3.4 fish per family) was genotyped using a 55K
SNP array. After QC processing, a total of 43,346 SNPs and
1103 fish remained for downstream analyses. Genomic herit-
ability estimated using the weighted single-step GBLUP
model was 0.33 ± 0.04, which is notably higher than the pedi-
gree estimate. The single SNP genome-wide association ana-
lysis revealed a significant QTL in chromosome Ssa13
(Fig. 2a, Table 1, Supplementary Table 1; a single SNP in
chromosome Ssa16 also reached the significance threshold,
but was not supported by other SNPs in the region and ex-
plained a very small percentage of the total genetic variance,
therefore it was not considered). The significant QTL in
chromosome Ssa13 explained ~ 3% of the genetic variance
in resistance to ISAV, while five other genomic regions each
explained more than 1%, with the largest-effect detected in
Ssa18 (4.8%) (Fig. 2b, Table 1, Supplementary Table 1).
Overall, the data supported a polygenic basis for host resist-
ance to ISAV, with minor effect loci distributed across sev-
eral chromosomes.
Transcriptomic response to ISAV
Based on the genomic estimated breeding values for re-
sistance to ISAV and family mortalities, 4 resistant and 4
susceptible animals were selected at each of three time-
points (0, 7 and 14 days post infection (dpi)). These early
timepoints were selected to increase the chance of de-
tecting potential genetic resistance mechanisms. The
average GEBVs of resistance to ISAV for the more re-
sistant and more susceptible groups across all timepoints
were 0.05 and 0.41 (survival = 0, mortality = 1), respect-
ively, with average family survival rates of 64 and 17%
for each group. The transcriptome of the heart samples
from these animals was sequenced using Illumina tech-
nology, obtaining an average of 51 million of reads per
sample. Principal component analyses highlighted that
control and infected samples clustered separately ac-
cording to the two first principal components, which ex-
plained 20 and 13% of the total variance (Fig. 3).
However, there was no clear differentiation between the
challenged timepoints, nor between the resistant and
susceptible samples (Supplementary Fig. 1).
Although the differentiation between the sampling
timepoints based on all transcript data was not clear cut,
there was a notable response to ISAV observed in the
heart samples both at 7 and 14 dpi, with 4927 and 2437
differentially expressed genes when compared to con-
trols, respectively (Fig. 4 & Supplementary Table 2). A
large proportion of the genes differentially expressed at
7 days were also differentially expressed at 14 dpi (1511
genes; Fig. 4a).
Several genes in the interferon pathway are mildly
down-regulated at 7 dpi (Fig. 4b), suggesting an initial
repression of the antiviral pathway early in infection, as
shown by several interferon regulatory factor (IRF)
mRNAs being significantly lower in infected samples
compared to controls (albeit with small fold change).
However, at 14 dpi, several interferon response genes
showed up-regulation, such as Mx1, Mx3 or one copy of
Interferon-induced Very Large GTPase 1 (GVINP1, an-
other copy of the gene is down-regulated) (Fig. 4c).
Fig. 1 Patterns of mortality observed during the ISAV challenge. a Percentage of survival for each full-sibling family at the end of the challenge,
and b) percentage of surviving fish in the population throughout the duration of the challenge
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Other well-characterised immune genes showed differen-
tial expression, such as Tumor Necrosis Factor alpha,
were down-regulated at 7 days but not at 14 dpi. Down-
regulation of numerous complement genes was observed
at both timepoints, and in fact KEGG pathway enrichment
analyses (Table 2 & Supplementary Table 3) revealed a
clear and increasing down-regulation of the complement
and coagulation cascades pathway during infection. Al-
most all the complement and coagulation cascade genes
showing putative downregulation at 7 dpi presented even
Fig. 2 Weighted single-step genome-wide association analyses for resistance to ISAV in the challenged Atlantic salmon population. a Shows the
p-value for each SNP in a single SNP GWAS, and the red dotted horizontal line represents the significance threshold (p-value < 0.05 after
Bonferroni correction); b shows the percentage of additive variation explained by windows of 20 consecutive SNPs. 17 SNPs are placed in
scaffolds not assigned to chromosomes (ICSASG_v2; Lien et al. 2016) and are not shown. These unassigned SNPs explained less than 0.01% of the
genetic variance and were not significantly associated with resistance to ISA
Table 1 Top 10 SNPs associated with resistance to ISAV according to p-value and percentage of genetic variation explained (p-value
< 0.05)
Chr. Position Pval Gen.Var. (%) Chr. Position Pval Gen.Var. (%)
16 31,177,052 4.77E-08 0.01 18 5,920,835 1.52E-04 4.80
13 16,490,837 2.06E-07 3.13 2 45,107,000 9.75E-03 4.13
13 16,491,495 1.50E-06 1.47 18 5,928,874 1.23E-05 3.60
13 16,449,439 9.14E-06 2.75 13 16,490,837 2.06E-07 3.13
18 5,928,874 1.23E-05 3.60 13 16,474,523 1.08E-03 3.09
13 18,222,026 1.49E-05 1.23 9 63,708,663 5.62E-04 2.84
13 18,189,947 1.28E-04 1.97 9 63,494,740 3.04E-02 2.82
18 5,920,835 1.52E-04 4.80 9 63,493,152 9.60E-03 2.82
13 18,220,651 2.34E-04 1.25 9 63,275,439 8.06E-03 2.80
9 63,755,526 4.62E-04 2.55 13 164,49,439 9.14E-06 2.75
Gervais et al. BMC Genomics          (2021) 22:345 Page 4 of 14
larger negative fold changes in expression at 14 dpi, and
additional genes from the same pathway showed statisti-
cally significant down-regulation (Supplementary Table 4).
Similarly, a consistent up-regulation of numerous meta-
bolic processes is observed at both 7 and 14 dpi. Several of
the pathways typically activated during innate immune re-
sponse to viruses, such as interferon, interleukin or in-
flammation pathways, are not enriched amongst the set of
up- or down-regulated genes, although the pathway
HTLV-I (human T-lymphotropic virus type 1) infection is
down-regulated at 7 dpi, and so are certain signalling
pathways closely related to innate immune responses such
as FoxO and mTOR signalling.
Genomic signatures of resistance to ISAV
To assess the functional genomic basis of resistance, 4 fish
of high resistance breeding values and 4 fish of low resist-
ance breeding values were compared at each of the three
timepoints (pre-challenge, 7 and 14 dpi). There were a
relatively small number of significantly differentially
expressed genes between resistant and susceptible fish
(13–18 DEG per timepoint; Fig. 5 & Supplementary file 5).
However, these included innate immune response genes
of interest such as E3 ubiquitin/ISG15 ligase TRIM25 (in-
volved in innate immune defence against viruses; more
expressed in resistant fish at 7 dpi, logFC = 3.90, albeit
mainly showing up-regulation in two resistant fish),
interferon-induced very large GTPase 1 (more expressed
in resistant fish at 14 dpi, logFC = 1.31), or transcription
factor Kruppel-like factor 2 (regulates inflammatory pro-
cesses; less expressed in resistant controls, logFC = − 1.03)
(Fig. 5).
Integration of genetic association and gene expression
To inform potential genes and mechanisms underlying
putative ISAV resistance QTLs, the gene expression re-
sults were overlaid onto the main genome-wide signifi-
cant QTL (Ssa13), and the genomic region explaining
Fig. 3 Principal Components Analysis showing the clustering of the
heart RNA-Seq data
Fig. 4 Differential expression of transcripts between ISAV-infected
and control fish. a Venn diagram depicting the number of common
and unique genes showing differential expression at 7 and 14 days
compared to control. b Volcano plot showing the differential
expression and differentially expressed interferon genes in control vs
7 dpi, and c controls vs 14 dpi. Each point in the plots represents a
gene, with its log2 fold change in the x-axis and its –log10 p-value in
the y-axis. Genes are classified in 4 categories depending on their FC
and FDR corrected p-value: i) grey = p-value > 0.05; ii) purple = p-
value < 0.05 and log2 fold change < |1.5|; iii) pink = p-value < 0.05
and log2 fold change > |1.5|
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the most genetic variance (Ssa18) (Fig. 6). For Ssa13, the
Eukaryotic translation initiation factor 4 gamma 1
(EIF4G1), up-regulated 14 days post infection, is one of
the closest genes to the most significant SNPs. For
Ssa18, the most significant SNPs overlap with the prob-
able E3 ubiquitin-protein ligase HERC4, which is up-
regulated in response to infection at both 7 and 14 dpi.
None of the genes showing differential expression be-
tween resistant and susceptible animals co-located with
the putative QTL.
Discussion
In this study, the genetic and genomic basis of resistance
to ISAV in Atlantic salmon was characterised in a large
population of Atlantic salmon parr derived from 194 fam-
ilies of a commercial breeding programme. The trait of
binary survival (reflecting host resistance) shows a moder-
ate genetic component and is therefore amenable to selec-
tion; heritability of resistance was estimated at 0.13 and
0.33 with the pedigree and genomic relationship matrices,
respectively. Higher heritability estimates using genomic
relationships have been observed compared to pedigree-
based estimates in previous studies investigating disease
resistance in aquaculture species [42, 43], potentially due
to high linkage disequilibrium due to recent selective
breeding causing overestimation of additive genetic vari-
ance using genomic markers [43]. Nonetheless, these re-
sults are in line with the range of previous heritability
estimates for resistance to ISAV in Atlantic salmon (0.13–
0.40 [23–28]). The genetic architecture of resistance to
ISAV in this population was polygenic, and major QTL
were not observed, as is common for disease resistance
traits [43–48]. However, one genome-wide significant
QTL was detected on Ssa13, and an additional three gen-
omic regions explaining > 2.5% of the genetic variation in
resistance to ISAV were detected (Ssa18, Ssa02, Ssa09).
A previous study investigating host resistance to ISAV
also detected a SNP marker associated with survival to
ISAV on Ssa13, however the most signifiant SNPs in
the two putative QTL are almost 50Mb apart [28]. To-
gether with two additional previous studies, putative
QTL affecting resistance to ISAV have been mapped on
12 different chromosomes [28–30], none of which were
significantly associated with resistance in the current
study. While the highly polygenic nature of ISAV and
the different origins of the populations studied can ex-
plain the different heritabilities and lack of overlap be-
tween GWAS studies, it is also plausible that differences
in the challenge model have a large effect over the trait
of resistance to ISAV. One of the studies employed a
challenge model based on intraperitoneal injection [30],
which ensures that all fish are infected at the same time
but neglects mucosal barriers that may play an import-
ant role in resistance. Furthermore, previous studies
using co-habitation have used a higher proportion of
‘Trojan’ fish, which may result in a higher infection pres-
sure and differences in host response [37]. Finally, the
genetic correlation between resistance to ISAV in fresh-
water (this study, [28]) and seawater [29] should be ad-
dressed in future studies; the life stage of the fish can
have an important impact on resistance to ISAV and
could also explain some of the differences between
studies.
The only genomic region with a significant association
with resistance to ISAV in our study was found in
chromosome Ssa13 (~ 16,490,837 bp), explaining ~ 3% of
the genetic variance. The closest gene to the most sig-
nificant SNPs showing differential expression is the
Eukaryotic translation initiation factor 4 gamma 1
(EIF4G1), which was up-regulated 14 days post infection.
This gene is part of the cellular translation machinery,
involved in recruiting mRNA to the ribosome. Interest-
ingly, this gene is directly targeted by the Influenza virus
NS1 protein to promote viral protein translation [49],
and if this interaction is compromised then viral replica-
tion is impaired [50]. EIF4G1 also interacts with the In-
fluenza polymerase PB2 to enable cap-independent
translation [51], and blocking this interaction inhibits In-
fluenza replication [52]. Therefore, this gene is a good
candidate for further investigation within the QTL for
resistance to ISAV in chromosome 13. Another genomic
region in chromosome 18, although not significant, con-
tained SNP windows which explained the most genetic
Table 2 Selected KEGG pathways identified as enriched among
differentially expressed genes
7 dpi
Up-regulated Down-regulated
KEGG N FE p KEGG N FE p
Carbon
metabolism
83 6.01 10−16 Complement and
coagulation
cascades
23 2.73 0.002
Aminoacyl-tRNA
biosynthesis
39 2.98 10−13 FoxO signalling
pathway
36 1.90 0.010
Citrate cycle
(TCA cycle)
38 2.27 10−11 HTLV-I infection 50 1.67 0.012
14 dpi
Up-regulated Down-regulated
KEGG N FE p KEGG N FE p
Carbon
metabolism
75 9.31 10−30 Complement and
coagulation
cascades
57 12.76 10− 36
Glycolysis /
gluconeogenesis
31 4.50 10−11 Staphylococcus
aureus infection
24 5.31 10−15
Biosynthesis of
amino acids
35 6.99 10−10 Systemic lupus
erythematosus
17 7.17 10−5
KEGG KEGG pathway, N Number of genes differentially expressed assigned to
the corresponding KEGG pathway, FE Fold enrichment, p False discovery rate
corrected p-value.
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Fig. 5 Heatmap showing the patterns of expression of genes differentially expressed between resistant and susceptible fish in each sample at all
of the three timepoints
Fig. 6 Genetic association and differential expression results in the genomic region with the lowest p-value (Ssa13) and the one explaining the
highest percentage of genetic variation (Ssa18). The SNPs explaining at least 1% of the genetic variance in each region are shown as red dots,
with the shading representing the percentage of genetic variance explained (darker points explaining more variance); the SNPs are placed on the
y-axis according to their GWAS –log 10 p-values (association with resistance to ISAV). The log2 fold change of the genes showing differential
expression versus controls at 7 dpi (light blue) or 14 dpi (dark blue) are shown as bars, with the scale on the left y-axis
Gervais et al. BMC Genomics          (2021) 22:345 Page 7 of 14
variance in our study (almost 5%). The closest gene to
this putative QTL showing expression differences is the
probable E3 ubiquitin-protein ligase HERC4 (HERC4),
up-regulated both at 7 and 14 days post infection. No in-
teractions between this gene and viral infections have been
described, however viruses, including Influenza, frequently
target the host ubiquitin machinery [53], and members of
the same family HERC5 and HERC6 have antiviral prop-
erties in mammals. These genes attach interferon-
stimulated gene 15 (ISG15) to target proteins in the pres-
ence of interferons [54], and HERC5 in fact targets the
critical Influenza virulence factor NS1 protein to inhibit
its replication [55]. While these genes are interesting can-
didates, we found no evidence of differences in their ex-
pression between ISAV resistant and susceptible fish,
which might not be surprising considering the polygenic
nature of ISAV resistance, the relatively small effect of
these QTL and the small sample size of our resistant vs
susceptible transcriptomic comparison. Additionally, these
genes could show tissue-specific responses, or not depend
on expression changes to have an impact on the course of
the disease. Nonetheless, these genes represent potential
targets for further downstream studies to try to under-
stand the genetic factors underlying these putative QTL
and more generally resistance to ISAV.
Putative virus-induced immunomodulation of
transcriptional response to ISAV in salmon
A relatively large transcriptomic response to ISAV infec-
tion was observed in the heart of Atlantic salmon at both
7 and 14 dpi. This response was characterised by a down-
regulation of the complement and coagulation cascades;
surprising considering the frequently observed symptoms
of the disease (erythrophagia and haemorrhages [14];). In
addition, a lower number of genes showed differential ex-
pression at 14 dpi than at 7 dpi, but the number of differ-
entially expressed genes involved in the complement and
coagulation cascades increased, suggesting potentially pro-
gressive immunomodulation by ISAV. Orthomyxoviruses
are capable of subverting the host complement system
through different mechanisms [56]. A general up-
regulation of various metabolic pathways was also ob-
served both at 7 and 14 dpi. Widespread metabolism dys-
regulation is commonly observed in diseased fish [57–59],
although generally down-regulated and ascribed to a
physiological response of the host to infection to adjust
cellular homeostasis or to reduced appetite. Nonetheless,
pathogens also reprogram the cellular metabolism of in-
fected cells to favour their replication [60], and therefore
the observed dysregulation could be a consequence of the
host-virus interaction. In fact, the infection strategy of in-
fluenza virus includes mechanisms to alter host transcrip-
tion and translation [61].
The observed interferon response was weaker than ex-
pected, with a few interferon-related genes showing
lower expression levels at 7 days than in controls, and
mild up-regulation of a few interferon genes at 14 dpi.
For instance Mx1, which has been shown to confer re-
sistance to ISAV in chinook salmon cells, was up-
regulated at 14 dpi [62]. In general, the gene expression
patterns suggest that the innate immune response was
relatively mild at 7 dpi and 14 dpi. This differs from pre-
vious studies on ISAV-infected salmon [33, 34, 36, 37].
There are two possible, non-exclusive explanations for
this result. First, tissue-specific regulation seems to play
an important role during ISAV infection [37], and previ-
ous research has been focused in immune-tissues, which
are more likely to exhibit dysregulation of genes associ-
ated with immunity. Secondly, a previous study on the
response of Atlantic salmon heart to ISAV only reported
significant differences in the expression of immune
genes at 21 dpi, albeit some genes started to show an
upward trend at 13 days [35]. Therefore, the relatively
early timepoints studied here, in comparison to other
studies, might affect the strength of the innate immune
response observed. Our selected timepoints reflect the
main goal of our study, which was to capture potential
early events that might influence the outcome of the in-
fection. A strong innate immune response may be ex-
pected in the first week following infection, but with the
cohabitation challenge model used, it is difficult to pre-
dict the precise time at which individual fish become in-
fected. Nonetheless, a clear transcriptomic response was
observed, which considering the stronger response to
ISAV at 7 dpi than at 14 dpi might suggest a mechanism
of immunoevasion of the virus. This immunoevasion
might not be effective later in the infection when viral
levels are high, which is consistent with the reported
positive correlation between virus abundance and the
magnitude of the immune response [34, 37, 63], and is
consistent with the up-regulation of several interferon
genes at 14 dpi.
The down-regulation of genes involved in the inter-
feron response (i.e. irf1, irf4 or irf8) in infected samples
at 7 dpi (and lack of up-regulation of other interferon
genes at this time point) suggests that ISAV modulates
this process as part of its infection and replication strat-
egy. Previous studies have demonstrated that segments 7
and 8 of the ISAV genome produce proteins with antag-
onist IFN properties, binding directly to IRFs [64] and
down-regulating type I IFN transcription activity [65].
Segment 7 specifically inhibits the transcription of mx
[66], which as mentioned above has been shown to con-
fer resistance to ISAV in chinook salmon cells [62]. This
active suppression of the interferon system is consistent
with previous studies in Influenza in human and chicken
[67, 68]. Additionally, SOCs and NLRc3 genes, which
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limit the inflammatory response [69, 70], are up-
regulated in infected samples, and cytokine induction is
not clearly observed, supporting the theory of the nega-
tive regulation of the innate immune response during
ISAV infection. It should be noted, however, that the re-
sults of the transcriptome profiling in the current study
pertain to heart tissue only, which suggests caution is re-
quired before making general interpretations. Other tis-
sues were sampled from the same fish, and this biobank of
samples could form the basis for future sequencing to give
a more holistic overview of host response to ISAV, and
the differences between resistant and susceptible fish.
Transcriptomic signatures of resistance to ISAV in Atlantic
salmon
Although the overall antiviral response was less striking
than expected, certain interferon-related genes are up-
regulated in response to ISAV (Mx1, Mx3, Irf7). Import-
antly, both gvinp1 and TRIM25, interferon stimulated
genes (ISG), were found to have higher average expres-
sion in resistant than in susceptible samples, although
the up-regulation of TRIM25 must be considered with
caution since there were only two resistant fish with a
very high expression of this gene. Gvinp1 is a protein
directly induced by the interferon pathway, but its func-
tion is not fully understood [71, 72]. On the other hand,
the function of the E3 ubiquitin / ISGA15 ligase
TRIM25 is well-characterised in mammals, where
TRIM25 is responsible for the ubiquitination of RIG-I,
leading to the activation of the downstream pathway and
increased interferon production [73], crucial for antiviral
innate immunity. Interestingly, Influenza A virus non-
structural protein 1 (NS1) specifically inhibits TRIM25-
mediated ubiquitination of RIG-I [74]. TRIM25 can also
inhibit viral RNA synthesis through direct binding to the
viral RNA polymerase complex (independent of its ubi-
quitin ligase activity), an activity that can also be inhib-
ited by the viral NS1 [75]. In summary, TRIM25 plays a
vital role in the host response to Influenza infection in
mammals, and is actively modulated by Orthomixo-
viruses. However, it is unclear whether this function is
conserved in teleost; although fish TRIM genes show
features suggesting a role in innate immunity, they show
important clade-specific diversifications [76]. Nonethe-
less, many TRIM genes are induced upon viral infection,
and some have been shown to trigger antiviral activity
in vitro [77]. In common carp, a gene also annotated as
TRIM25 was identified as a promising candidate for Koi
herpesvirus resistance [78], which suggests its relevance
in antiviral responses is well conserved.
While expression differences between resistant and sus-
ceptible fish are based on a small number of samples, and
none of these genes co-localise with any of the putative
QTL regions identified in this study, they represent a first
layer of information towards understanding ISAV resist-
ance. In particular, the functional relevance of TRIM25 in
response to Influenza, another Orthomixovirus, suggests
that this gene is a good target for future functional studies
to understand and increase resistance of Atlantic salmon
to ISAV.
Conclusion
Resistance to ISAV is moderately heritable and shows a
polygenic architecture amenable to genome-assisted se-
lection schemes, albeit a significant QTL was discovered
in chromosome Ssa13 explaining around 3% of the gen-
etic variance and could be prioritised in selection
schemes prior validation in follow-up studies. The heart
transcriptomes of selected genetically resistant and sus-
ceptible samples revealed a complex response, which
suggests a host-pathogen crosstalk regulating the innate
immune response and more specifically the interferon
pathway. In line with its polygenic architecture, the tran-
scriptomic signatures of resistance are diverse in nature;
nonetheless, TRIM25 could be a promising candidate for
further functional studies on resistance to ISAV. Gen-
ome editing experiments should inform the role of this
gene in the progression of the disease, and may help ob-
tain salmon stocks with increased resistance to ISAV in
the future, leading to increased stability, food security
and fish welfare.
Methods
Disease challenge and sampling
The population used for the ISAV challenge experiment
comprised 2833 parr fish (mean 37.5 ± 9.2 g) from 194
nuclear families originating from Benchmark Genetics
breeding programme. The challenge experiment and
sampling were conducted in the facilities of VESO Vikan
(Norway). All fish were PIT-tagged and transferred to
one 4 m3 tank where they were acclimated for 3 weeks
in fresh water at the following approximate conditions:
temperature 12 °C, stocking density 40 kg / m3, flow 5–
6 mg O2 / L and photoperiod regime L:D = 24:0. Post ac-
climation, 300 carrier fish (Atlantic salmon from the
same population) used for the cohabitation challenge
were intraperitoneally injected with 0.1 mL of ISAV
(Glaesvær, 080411, grown in ASK-cells, 2 passage, esti-
mated titre 106 PFU / mL [79]) and introduced to the
challenge tank with the naive fish. Fish were fed using
an automatic feeder during the challenge, with feeding
percentage updated weekly. Fish and tanks were moni-
tored on a daily basis, removing mortalities and mori-
bund fish (registered as dead), and recording
environmental parameters. Mortalities were registered
and sampled daily, and the trial was terminated when
the mortality level dropped to baseline levels (i.e. near
zero). The expected clinical signs of ISA infection were
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observed, and a small number of mortalities (n = 1–3)
were sampled daily and tested for ISAV using quantita-
tive RT-PCR (qRT-PCR) to confirm the virus was the
cause of death. To achieve this, a small sample of heart
tissue was stored in RNA-later at − 20 °C until process-
ing. Quantitative estimates of virus load were obtained
by qRT-PCR analyses which were performed by the Fish
Vet Group Norway (http://fishvetgroup.no/en/). The
majority of samples tested positive and had significant
ISAV titre from approximately 10 days post-challenge.
Adipose fin tissue samples from all fish were collected
and stored in ethanol for DNA extraction and genotyp-
ing. In addition, 30 of the challenged fish were termi-
nated at each of three time points (pre-infection, 7 dpi
and 14 dpi) for sampling of tissues for transcriptomic
analyses. In addition to fin clips, the hearts of a subset of
animals were collected into TRI Reagent (Sigma, UK)
and stored at − 20 °C until RNA extraction.
Genetic parameter estimation
Resistance to ISAV was measured as binary survival
(BS), mortalities were recorded as 0 and survivors as 1.
All challenged fish were used to estimate the genetic pa-
rameters for resistance to ISAV, using a probit link func-
tion and the ASREML software v4.1 [80]. The univariate
animal model used was:
y ¼ Xbþ Zuþ e
Where y is the vector of phenotypic records; b is the vec-
tor of fixed effects, which includes sex as fixed effect and the
first two principal components of the variance-standardized
relationship matrix and body weight at PIT-tagging as covar-
iates; u is the vector of random animal genetic effects which
assumes the following normal distribution ~ Nð0;Aσ2aÞ ,
where A is the additive relationship matrix and σ2a is the
additive genetic variance; e is the vector of residual effects
with a normal distribution assumed as ~ Nð0; Iσ2eÞ, where I
is the incidence matrix and σ2e is the residual variance; and X
and Z are design matrices for fixed and random effects, re-
spectively. Heritability was estimated as:
h2 ¼ σ
2
a
σ2a þ σ2e
Where σ2a is the additive genetic variance and σ
2
e is the esti-
mated residual variance, which was set as 1 (Gilmour et al. 2009).
Genotyping and GWAS
A total of 1367 samples were successfully genotyped for
a 55 K Affymetrix Axiom SNP array used routinely by
Benchmark Genetics in their commercial breeding
programme. DNA extraction from fin clips and SNP
array genotyping was performed by IdentiGEN (Dublin,
Ireland). Quality control (QC) was performed using
PLINK software v1.90 [81]. SNPs with minor allele fre-
quency (MAF) lower than 0.05 or significantly deviating
from Hardy–Weinberg Equilibrium (HWE) (p < 1e-6)
were removed for further analyses; SNPs and individuals
with a call rate lower than 99% were also excluded.
A weighted single-step GBLUP approach (wssGBLUP)
was used to estimate genomic heritability and to identify
the genomic regions associated with ISAV resistance.
This approach uses all animals with phenotypic data,
connecting genotyped and not genotyped fish through
the pedigree [82]. Pedigree and genotypic information
are combined to create an H matrix [83]. Thus, the in-
verse of this H matrix is:
H−1 ¼ A−1 þ 0 0
0 G−1−A−122
 
Where A−1 is the inverse of the pedigree-based relation-
ship matrix, A−122 represents the inverse of the A matrix, but
only considering the genotyped fish, and G−1 is the inverse
of the genomic relationship matrix. The statistical model for
the genetic parameter estimation and for the genome-wide
association study is identical as the one mentioned above,
but replacing the A matrix by the H matrix. Genomic herit-
ability using the H matrix was estimated as described above.
The variance obtained on the first iteration of wssGBLUP
for each SNP (single-step GWAS) was used as the weight in
the analyses. The variances were estimated based on the al-
lele frequency and marker effect [84]. A threshold model
was fitted for BS using the THRGIBSS1F90 function of
BLUPF90 [85], and a total of 200,000 Markov Chain Monte
Carlo (MCMC) iterations were fitted. From these, 20,000
were burned-in, and 1 from every 50 of the remaining 180,
000 samples were saved.
Additionally, a mixed linear model, using the leaving-one-
chromosome-out (LOCO) approach was fitted to identify
SNPs associated with resistance to ISAV, through the GCTA
v.1.92.2. software [86]. The fitted model was identical as the
one described for the wssGBLUP approach, although a G
matrix was used. For a SNP to be significantly associated at
genome-wide level with resistance to ISAV, it must surpass
the Bonferroni-corrected significance threshold (α/n), where
a and n represent the significance level (0.05) and the num-
ber of SNP that surpassed the QC, respectively.
Finally, the p-values for each SNP and the proportion
of the genetic variance explained by 20 adjacent SNP
window were plotted with R/CMplot.
The wssGBLUP approach was used for the estimation
of the genetic parameters and the genome-wide associ-
ation study was also used to predict the genomic esti-
mated breeding values (gEBVs) for resistance to ISAV,
estimating the genetic resistance and susceptibility of the
fish sampled for transcriptomic experiments.
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RNA extraction and RNA sequencing
For each timepoint (control, 7 dpi and 14 dpi) 4 fish with
high breeding values for resistance and 4 fish with low
breeding values for resistance, representing 8 different
families, were selected according to their estimated gen-
omic breeding value for ISAV resistance. Heart RNA was
extracted from preserved tissue samples (n = 24; 8 x con-
trols, 8 × 7 dpi, 8 × 14 dpi) in TRI Reagent (Sigma, UK)
and RNA extracted following the manufacturer’s instruc-
tions. The RNA pellet was eluted in 15 μL of nuclease-free
water and quantified on a Nanodrop 1000 spectropho-
tometer (NanoDrop Technologies) prior to DNAse treat-
ment with QuantiTect® Reverse Transcription kit
(Qiagen). The quality of the RNA was examined by elec-
trophoresis on a 1% agarose gel (Sigma Aldrich), prepared
in Tris-Acetate-EDTA (TAE) buffer, stained with 1%
SYBR Safe (Sigma Aldrich) and run at 80 V for 30min.
Sample concentration was measured with Invitrogen
Qubit 3.0 Fluorometer using the Qubit RNA HS Assay Kit
(ThermoFisher Scientific). PolyA RNA-Seq libraries were
prepared using Illumina’s TruSeq RNA Library Prep Kit
v2 by Oxford Genomic Centre, and sequenced on an Illu-
mina Novaseq6000 as 150 bp paired-end reads yielding an
average of 51M reads per sample (minimum 38M).
RNA-Seq analyses
Raw reads were quality trimmed using Trimgalore v0.6.3.
Briefly, adapter sequences were removed, low quality bases
were filtered (Phred score < 20) and reads with less than 20 bp
were discarded. Trimmed reads were then pseudoaligned
against the Atlantic salmon reference transcriptome (ICSA
SG_v2 Annotation Release 100) [87] using kallisto v0.44.0
[88]. Transcript level expression was imported into R v3.6 [89]
and summarised to the gene level using the R/tximport
v1.10.1 [90]. Differential expression analysis was performed
using R/Deseq2 v1.22.2 [91], and genes with False Discovery
Rate adjusted p-values < 0.05 were considered to be differen-
tially expressed. Kyoto Encyclopedia of Genes and Genomes
(KEGG) enrichment analyses were carried out using KOBAS
v3.0.3 [92]. Briefly, salmon genes were annotated against the
KEGG protein database [93] to determine KEGG Orthology
(KO). KEGG enrichment for differentially expressed gene lists
was tested by comparison to the whole set of expressed genes
(average of > 10 normalised reads) in the corresponding tissue
using Fisher’s Exact Test. KEGG pathways with ≥5 DE genes
assigned and showing a Benjamini-Hochberg FDR corrected
p-value < 0.05 were considered enriched.
Data availability
RNA sequencing raw reads have been deposited in
the NCBI’s Short Read Archive (SRS) repository with
accession number PRJNA647285. The DESeq2
normalised gene expression matrix is available as sup-
plementary file 1.
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s12864-021-07671-6.
Additional file 1.
Additional file 2.
Additional file 3.
Additional file 4.
Additional file 5.
Additional file 6.
Additional file 7.
Acknowledgements
Not applicable.
Authors’ contributions
RH, SAM and DR were responsible for the concept and design of this work.
BH and AE were responsible for the disease challenge. OG, AB, AP and RG
analysed the data. OG, DR and RH drafted the manuscript. All authors
reviewed and approved the manuscript.
Funding
The authors gratefully acknowledge funding from BBSRC (BB/R008612/1, BB/
R008973/1), in addition to BBSRC Institute Strategic Programme Grants to the
Roslin Institute (BB/P013759/1 and BB/P013740/1).
Availability of data and materials
The datasets generated and analysed during the current study are available
in the NCBI’s Short Read Archive (SRS) repository with accession number
PRJNA647285.
Declarations
Ethics approval and consent to participate
The challenge experiment and associated procedures were performed at
VESO Vikan with approval from the Norwegian Food Safety Authority,
National Assignments Department, approval no. 16421, in accordance with
the Norwegian Animal Welfare Act. All methods were carried out in
accordance with relevant guidelines and regulations and in compliance with
the ARRIVE guidelines.
Consent for publication
Not applicable.
Competing interests
A commercial organisation (Benchmark Holdings plc) was involved in the
development of this study. BH and AET work for Benchmark. The remaining
authors declare that they have no competing interests.
Author details
1The Roslin Institute and Royal (Dick) School of Veterinary Studies, University
of Edinburgh, Edinburgh, UK. 2Benchmark Genetics Norway, Sandviksboder
3A, N-5035 Bergen, AS, Norway. 3Benchmark Genetics Ltd, Benchmark House,
8 Smithy Wood Drive, Sheffield S35 1QN, UK. 4School of Biological Sciences,
University of Aberdeen, Aberdeen, UK.
Received: 30 November 2020 Accepted: 30 April 2021
References
1. Gordon IJ. Review: livestock production increasingly influences wildlife
across the globe. Animal. 2018;12:s372–82.
Gervais et al. BMC Genomics          (2021) 22:345 Page 11 of 14
2. Zhang X, Cai X. Climate change impacts on global agricultural land
availability. Environ Res Lett. 2011;6(1):014014. https://doi.org/10.1088/1748-
9326/6/1/014014.
3. Ghosh A, Misra S, Bhattacharyya R, Sarkar A, Singh AK, Tyagi VC, et al.
Agriculture, dairy and fishery farming practices and greenhouse gas
emission footprint: a strategic appraisal for mitigation. Environ Sci Pollut Res.
2020;27(10):10160–84. https://doi.org/10.1007/s11356-020-07949-4.
4. Godfray HCJ, Beddington JR, Crute IR, Haddad L, Lawrence D, Muir JF, et al.
Food security: the challenge of feeding 9 billion people. Science. 2010;
327(5967):812–8. https://doi.org/10.1126/science.1185383.
5. Fry JP, Mailloux NA, Love DC, Milli MC, Cao L. Feed conversion efficiency in
aquaculture: do we measure it correctly? Environ Res Lett. 2018;13(2):
024017. https://doi.org/10.1088/1748-9326/aaa273.
6. FAO. The state of world fisheries and aquaculture 2020: sustainability in
action. Rome: FAO; 2020. https://doi.org/10.4060/ca9229en. Also Available
in: Chinese Spanish Arabic French Russian
7. MacLachlan NJ, Dubovi EJ. Chapter 21 - Orthomyxoviridae. In: Fenner’s
veterinary virology. 5th ed. Boston: Academic; 2017. p. 389–410. https://doi.
org/10.1016/B978-0-12-800946-8.00021-0.
8. Nogales A, Martinez-Sobrido L, Topham DJ, DeDiego ML. Modulation of
innate immune responses by the influenza a NS1 and PA-X proteins.
Viruses. 2018;10(12). https://doi.org/10.3390/v10120708.
9. Rimstad E, Markussen T. Infectious salmon anaemia virus—molecular
biology and pathogenesis of the infection. J Appl Microbiol. 2019. https://
doi.org/10.1111/jam.14567.
10. Madhun AS, Mæhle S, Wennevik V, Karlsbakk E. Prevalence and genotypes
of infectious salmon anaemia virus (ISAV) in returning wild Atlantic salmon
(Salmo salar L.) in northern Norway. J Fish Dis. 2019;42(8):1217–21. https://
doi.org/10.1111/jfd.13021.
11. OIE-Listed diseases 2020: OIE - World Organisation for Animal Health.
https://www.oie.int/en/animal-health-in-the-world/oie-listed-diseases-2020/.
Accessed 17 Nov 2020.
12. Bouchard D, Brockway K, Giray C, Keleher W. First report of infectious
salmon anemia (ISA) in the United States. Bull Eur Assoc Fish Pathol. 2001;
21:86.
13. Bouchard D, Keleher W, Opitz HM, Blake S, Edwards KC, Nicholson BL.
Isolation of infectious salmon anemia virus (ISAV) from Atlantic salmon in
New Brunswick, Canada. Dis Aquat Organ. 1999;35(2):131–7. https://doi.
org/10.3354/dao035131.
14. Godoy MG, Aedo A, Kibenge MJT, Groman DB, Yason CV, Grothusen H, et al.
First detection, isolation and molecular characterization of infectious salmon
anaemia virus associated with clinical disease in farmed Atlantic salmon
(Salmo salar) in Chile. BMC Vet Res. 2008;4(1):28. https://doi.org/10.1186/174
6-6148-4-28.
15. Lovely JE, Dannevig BH, Falk K, Hutchin L, MacKinnon AM, Melville KJ, et al.
First identification of infectious salmon anaemia virus in North America with
haemorrhagic kidney syndrome. Dis Aquat Org. 1999;35(2):145–8. https://
doi.org/10.3354/dao035145.
16. Mardones FO, Perez AM, Carpenter TE. Epidemiologic investigation of the
re-emergence of infectious salmon anemia virus in Chile. Dis Aquat Org.
2009;84(2):105–14. https://doi.org/10.3354/dao02040.
17. Mullins JED, Groman D, Wadowska D. Infectious salmon anaemia in salt
water Atlantic salmon (Salmo salar L.) in new Brunswick, Canada. Bull Eur
Assoc Fish Pathol. 1998;18:110.
18. Rodger HD, Richards RH. Haemorrhagic smolt syndrome: a severe anaemic
condition in farmed salmon in Scotland. Vet Rec. 1998;142(20):538–41.
https://doi.org/10.1136/vr.142.20.538.
19. Aamelfot M, Dale OB, Falk K. Infectious salmon anaemia – pathogenesis and
tropism. J Fish Dis. 2014;37(4):291–307. https://doi.org/10.1111/jfd.12225.
20. Dannevig BH, Mjaaland S, Rimstad E. Infectious Salmon anemia virus. In:
Mahy BWJ, Van Regenmortel MHV, editors. Encyclopedia of virology. 3rd ed.
Oxford: Academic; 2008. p. 89–95. https://doi.org/10.1016/B978-01237441
0-4.00773-1.
21. Falk K. Vaccination against infectious Salmon anemia. In: Fish vaccination.
Chichester: Wiley; 2014. p. 313–20. https://doi.org/10.1002/9781118806913.
ch26.
22. Houston RD, Bean TP, Macqueen DJ, Gundappa MK, Jin YH, Jenkins TL, et al.
Harnessing genomics to fast-track genetic improvement in aquaculture. Nat
Rev Genet. 2020;21(7):389–409. https://doi.org/10.1038/s41576-020-0227-y.
23. Gjerde B, Evensen Ø, Bentsen HB, Storset A. Genetic (co) variation of vaccine
injuries and innate resistance to furunculosis (Aeromonas salmonicida) and
infectious salmon anaemia (ISA) in Atlantic salmon (Salmo salar).
Aquaculture. 2009;287(1-2):52–8. https://doi.org/10.1016/j.aquaculture.2008.1
0.028.
24. Gjøen HM, Bentsen HB. Past, present, and future of genetic improvement in
salmon aquaculture. ICES J Mar Sci. 1997;54(6):1009–14. https://doi.org/10.1
016/S1054-3139(97)80005-7.
25. Kjøglum S, Henryon M, Aasmundstad T, Korsgaard I. Selective breeding can
increase resistance of Atlantic salmon to furunculosis, infectious salmon
anaemia and infectious pancreatic necrosis. Aquac Res. 2008;39(5):498–505.
https://doi.org/10.1111/j.1365-2109.2008.01904.x.
26. Ødegård J, Olesen I, Gjerde B, Klemetsdal G. Evaluation of statistical models
for genetic analysis of challenge-test data on ISA resistance in Atlantic
salmon (Salmo salar): prediction of progeny survival. Aquaculture. 2007;
266(1-4):70–6. https://doi.org/10.1016/j.aquaculture.2007.02.012.
27. Ødegård J, Olesen I, Gjerde B, Klemetsdal G. Positive genetic correlation
between resistance to bacterial (furunculosis) and viral (infectious salmon
anaemia) diseases in farmed Atlantic salmon (Salmo salar). Aquaculture.
2007;271(1-4):173–7. https://doi.org/10.1016/j.aquaculture.2007.06.006.
28. Holborn MK, Ang KP, Elliott JAK, Powell F, Boulding EG. Genome wide
analysis of infectious salmon anemia resistance in commercial Saint John
River Atlantic salmon. Aquaculture. 2020;514:734514. https://doi.org/10.1016/
j.aquaculture.2019.734514.
29. Dussault FM, Ang KP, Elliott JAK, Glebe BD, Leadbeater S, Manning AJ, et al.
Mapping quantitative trait loci for infectious salmon anaemia resistance in a
north American strain of Atlantic salmon. Aquac Res. 2019;51:80–90.
30. Moen T, Sonesson AK, Hayes B, Lien S, Munck H, Meuwissen TH. Mapping of a
quantitative trait locus for resistance against infectious salmon anaemia in Atlantic
salmon (Salmo Salar): comparing survival analysis with analysis on affected/resistant
data. BMC Genet. 2007;8(1):53. https://doi.org/10.1186/1471-2156-8-53.
31. Li J, Boroevich KA, Koop BF, Davidson WS. Comparative genomics identifies
candidate genes for infectious Salmon anemia (ISA) resistance in Atlantic
Salmon (Salmo salar). Mar Biotechnol N Y N. 2011;13(2):232–41. https://doi.
org/10.1007/s10126-010-9284-0.
32. Andresen AMS, Boudinot P, Gjøen T. Kinetics of transcriptional response
against poly (I:C) and infectious salmon anemia virus (ISAV) in Atlantic
salmon kidney (ASK) cell line. Dev Comp Immunol. 2020;110:103716. https://
doi.org/10.1016/j.dci.2020.103716.
33. Dettleff P, Moen T, Santi N, Martinez V. Transcriptomic analysis of spleen
infected with infectious salmon anemia virus reveals distinct pattern of viral
replication on resistant and susceptible Atlantic salmon (Salmo salar). Fish
Shellfish Immunol. 2017;61:187–93. https://doi.org/10.1016/j.fsi.2017.01.005.
34. Jørgensen SM, Afanasyev S, Krasnov A. Gene expression analyses in Atlantic
salmon challenged with infectious salmon anemia virus reveal differences
between individuals with early, intermediate and late mortality. BMC
Genomics. 2008;9(1):179. https://doi.org/10.1186/1471-2164-9-179.
35. Lauscher A, Krossøy B, Frost P, Grove S, König M, Bohlin J, et al. Immune
responses in Atlantic salmon (Salmo salar) following protective vaccination
against infectious salmon anemia (ISA) and subsequent ISA virus infection.
Vaccine. 2011;29(37):6392–401. https://doi.org/10.1016/j.vaccine.2011.04.074.
36. LeBlanc F, Arseneau JR, Leadbeater S, Glebe B, Laflamme M, Gagné N.
Transcriptional response of Atlantic salmon (Salmo salar) after primary
versus secondary exposure to infectious salmon anemia virus (ISAV). Mol
Immunol. 2012;51(2):197–209. https://doi.org/10.1016/j.molimm.2012.03.021.
37. Valenzuela-Miranda D, Boltaña S, Cabrejos ME, Yáñez JM, Gallardo-Escárate
C. High-throughput transcriptome analysis of ISAV-infected Atlantic salmon
Salmo salar unravels divergent immune responses associated to head-
kidney, liver and gills tissues. Fish Shellfish Immunol. 2015;45(2):367–77.
https://doi.org/10.1016/j.fsi.2015.04.003.
38. Gratacap RL, Wargelius A, Edvardsen RB, Houston RD. Potential of genome
editing to improve aquaculture breeding and production. Trends Genet.
2019;35(9):672–84. https://doi.org/10.1016/j.tig.2019.06.006.
39. Zenger KR, Khatkar MS, Jones DB, Khalilisamani N, Jerry DR, Raadsma HW.
Genomic selection in aquaculture: application, limitations and opportunities
with special reference to marine shrimp and pearl oysters. Front Genet.
2019;9. https://doi.org/10.3389/fgene.2018.00693.
40. Aslam ML, Robledo D, Krasnov A, Moghadam HK, Hillestad B, Houston RD,
et al. Quantitative trait loci and genes associated with salmonid alphavirus load
in Atlantic salmon: implications for pancreas disease resistance and tolerance.
Sci Rep. 2020;10(1):10393. https://doi.org/10.1038/s41598-020-67405-8.
41. Robledo D, Hamilton A, Gutiérrez AP, Bron JE, Houston RD. Characterising
the mechanisms underlying genetic resistance to amoebic gill disease in
Gervais et al. BMC Genomics          (2021) 22:345 Page 12 of 14
Atlantic salmon using RNA sequencing. BMC Genomics. 2020;21(1):271.
https://doi.org/10.1186/s12864-020-6694-x.
42. Bangera R, Correa K, Lhorente JP, Figueroa R, Yáñez JM. Genomic
predictions can accelerate selection for resistance against Piscirickettsia
salmonis in Atlantic salmon (Salmo salar). BMC Genomics. 2017;18(1):121.
https://doi.org/10.1186/s12864-017-3487-y.
43. Palaiokostas C, Cariou S, Bestin A, Bruant J-S, Haffray P, Morin T, et al.
Genome-wide association and genomic prediction of resistance to viral
nervous necrosis in European sea bass (Dicentrarchus labrax) using RAD
sequencing. Genet Sel Evol GSE. 2018;50:30.
44. Barría A, Christensen KA, Yoshida GM, Correa K, Jedlicki A, Lhorente JP, et al.
Genomic predictions and genome-wide association study of resistance
against Piscirickettsia salmonis in Coho Salmon (Oncorhynchus kisutch) using
ddRAD sequencing. G3 Bethesda Md. 2018;8:1183–94.
45. Robledo D, Gutiérrez AP, Barría A, Lhorente JP, Houston RD, Yáñez JM.
Discovery and functional annotation of quantitative trait loci affecting
resistance to sea lice in Atlantic Salmon. Front Genet. 2019;10:56. https://doi.
org/10.3389/fgene.2019.00056.
46. Robledo D, Matika O, Hamilton A, Houston RD. Genome-wide association
and genomic selection for resistance to amoebic gill disease in Atlantic
Salmon. G3 Bethesda Md. 2018;8:1195–203.
47. Vallejo RL, Cheng H, Fragomeni BO, Shewbridge KL, Gao G, MacMillan JR,
et al. Genome-wide association analysis and accuracy of genome-enabled
breeding value predictions for resistance to infectious hematopoietic
necrosis virus in a commercial rainbow trout breeding population. Genet
Sel Evol GSE. 2019;51(1):47. https://doi.org/10.1186/s12711-019-0489-z.
48. Wang W, Tan S, Luo J, Shi H, Zhou T, Yang Y, et al. GWAS analysis indicated
importance of NF-κB signaling pathway in host resistance against motile
Aeromonas septicemia disease in catfish. Mar Biotechnol N Y N. 2019;21(3):
335–47. https://doi.org/10.1007/s10126-019-09883-0.
49. Aragón T, de la Luna S, Novoa I, Carrasco L, Ortín J, Nieto A. Eukaryotic
translation initiation factor 4GI is a cellular target for NS1 protein, a
translational activator of influenza virus. Mol Cell Biol. 2000;20(17):6259–68.
https://doi.org/10.1128/MCB.20.17.6259-6268.2000.
50. Zhou H, Zhu J, Tu J, Zou W, Hu Y, Yu Z, et al. Effect on virulence and pathogenicity
of H5N1 influenza a virus through truncations of NS1 eIF4GI binding domain. J
Infect Dis. 2010;202(9):1338–46. https://doi.org/10.1086/656536.
51. Yángüez E, Rodriguez P, Goodfellow I, Nieto A. Influenza virus polymerase
confers independence of the cellular cap-binding factor eIF4E for viral
mRNA translation. Virology. 2012;422(2):297–307. https://doi.org/10.1016/j.
virol.2011.10.028.
52. Yuan S, Chu H, Ye J, Hu M, Singh K, Chow BK, et al. Peptide-mediated
interference of PB2-eIF4G1 interaction inhibits influenza a viruses' replication
in vitro and in vivo. ACS Infect Dis. 2016;2(7):471–7. https://doi.org/10.1021/a
csinfecdis.6b00064.
53. Rudnicka A, Yamauchi Y. Ubiquitin in influenza virus entry and innate
immunity. Viruses. 2016;8(10):293. https://doi.org/10.3390/v8100293.
54. Wang Y, Argiles-Castillo D, Kane EI, Zhou A, Spratt DE. HECT E3 ubiquitin
ligases – emerging insights into their biological roles and disease relevance.
J Cell Sci. 2020;133:jcs228072.
55. Tang Y, Zhong G, Zhu L, Liu X, Shan Y, Feng H, et al. Herc5 attenuates
influenza a virus by catalyzing ISGylation of viral NS1 protein. J Immunol.
2010;184(10):5777–90. https://doi.org/10.4049/jimmunol.0903588.
56. Agrawal P, Nawadkar R, Ojha H, Kumar J, Sahu A. Complement evasion
strategies of viruses: an overview. Front Microbiol. 2017;8. https://doi.org/1
0.3389/fmicb.2017.01117.
57. Ronza P, Robledo D, Bermúdez R, Losada AP, Pardo BG, Sitjà-Bobadilla A, et al.
RNA-seq analysis of early enteromyxosis in turbot (Scophthalmus maximus):
new insights into parasite invasion and immune evasion strategies. Int J
Parasitol. 2016;46(8):507–17. https://doi.org/10.1016/j.ijpara.2016.03.007.
58. Tang Y, Xin G, Zhao L-M, Huang L-X, Qin Y-X, Su Y-Q, et al. Novel insights
into host-pathogen interactions of large yellow croakers (Larimichthys
crocea) and pathogenic bacterium pseudomonas plecoglossicida using
time-resolved dual RNA-seq of infected spleens. Zool Res. 2020;41(3):314–27.
https://doi.org/10.24272/j.issn.2095-8137.2020.035.
59. Valenzuela-Miranda D, Gallardo-Escárate C. Dual RNA-Seq uncovers
metabolic amino acids dependency of the intracellular bacterium
Piscirickettsia salmonis infecting Atlantic Salmon. Front Microbiol. 2018;9.
https://doi.org/10.3389/fmicb.2018.02877.
60. Eisenreich W, Rudel T, Heesemann J, Goebel W. How viral and intracellular
bacterial pathogens reprogram the metabolism of host cells to allow their
intracellular replication. Front Cell Infect Microbiol. 2019;9. https://doi.org/1
0.3389/fcimb.2019.00042.
61. Bercovich-Kinori A, Tai J, Gelbart IA, Shitrit A, Ben-Moshe S, Drori Y, et al. A
systematic view on influenza induced host shutoff. eLife. 2016;5. https://doi.
org/10.7554/eLife.18311.
62. Kibenge MJ, Munir K, Kibenge FS. Constitutive expression of Atlantic salmon
Mx1 protein in CHSE-214 cells confers resistance to infectious Salmon
Anaemia virus. Virol J. 2005;2(1):75. https://doi.org/10.1186/1743-422X-2-75.
63. McBeath A, Aamelfot M, Christiansen DH, Matejusova I, Markussen T,
Kaldhusdal M, et al. Immersion challenge with low and highly virulent
infectious salmon anaemia virus reveals different pathogenesis in Atlantic
salmon, Salmo salar L. J Fish Dis. 2015;38(1):3–15. https://doi.org/10.1111/
jfd.12253.
64. Li C, Greiner-Tollersrud L, Robertsen B. Infectious salmon anemia virus
segment 7 ORF1 and segment 8 ORF2 proteins inhibit IRF mediated
activation of the Atlantic salmon IFNa1 promoter. Fish Shellfish Immunol.
2016;52:258–62. https://doi.org/10.1016/j.fsi.2016.03.038.
65. García-Rosado E, Markussen T, Kileng Ø, Baekkevold ES, Robertsen B, Mjaaland
S, et al. Molecular and functional characterization of two infectious salmon
anaemia virus (ISAV) proteins with type I interferon antagonizing activity. Virus
Res. 2008;133(2):228–38. https://doi.org/10.1016/j.virusres.2008.01.008.
66. Dahle MK, Jørgensen JB. Antiviral defense in salmonids – Mission made
possible? Fish Shellfish Immunol. 2019;87:421–37. https://doi.org/10.1016/j.
fsi.2019.01.043.
67. Kochs G, García-Sastre A, Martínez-Sobrido L. Multiple anti-interferon actions
of the influenza a virus NS1 protein. J Virol. 2007;81(13):7011–21. https://doi.
org/10.1128/JVI.02581-06.
68. Marcus PI, Rojek JM, Sekellick MJ. Interferon induction and/or production
and its suppression by influenza a viruses. J Virol. 2005;79(5):2880–90.
https://doi.org/10.1128/JVI.79.5.2880-2890.2005.
69. Dalpke A, Heeg K, Bartz H, Baetz A. Regulation of innate immunity by
suppressor of cytokine signaling (SOCS) proteins. Immunobiology. 2008;
213(3-4):225–35. https://doi.org/10.1016/j.imbio.2007.10.008.
70. Gültekin Y, Eren E, Özören N. Overexpressed NLRC3 acts as an anti-
inflammatory cytosolic protein. J Innate Immun. 2015;7(1):25–36. https://doi.
org/10.1159/000363602.
71. MacMicking JD. IFN-inducible GTPases and immunity to intracellular
pathogens. Trends Immunol. 2004;25(11):601–9. https://doi.org/10.1016/j.it.2
004.08.010.
72. Pilla-Moffett D, Barber MF, Taylor GA, Coers J. Interferon-inducible GTPases
in host resistance, inflammation and disease. J Mol Biol. 2016;428(17):3495–
513. https://doi.org/10.1016/j.jmb.2016.04.032.
73. Gack MU, Shin YC, Joo C-H, Urano T, Liang C, Sun L, et al. TRIM25 RING-
finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.
Nature. 2007;446(7138):916–20. https://doi.org/10.1038/nature05732.
74. Gack MU, Albrecht RA, Urano T, Inn K-S, Huang I-C, Carnero E, et al.
Influenza a virus NS1 targets the ubiquitin ligase TRIM25 to evade
recognition by RIG-I. Cell Host Microbe. 2009;5(5):439–49. https://doi.org/1
0.1016/j.chom.2009.04.006.
75. Meyerson NR, Zhou L, Guo YR, Zhao C, Tao YJ, Krug RM, et al. Nuclear
TRIM25 specifically targets influenza virus Ribonucleoproteins to block the
onset of RNA chain elongation. Cell Host Microbe. 2017;22:627–638.e7.
76. van der Aa LM, Levraud J-P, Yahmi M, Lauret E, Briolat V, Herbomel P, et al.
A large new subset of TRIM genes highly diversified by duplication and
positive selection in teleost fish. BMC Biol. 2009;7:7.
77. Langevin C, Levraud J-P, Boudinot P. Fish antiviral tripartite motif (TRIM)
proteins. Fish Shellfish Immunol. 2019;86:724–33. https://doi.org/10.1016/j.
fsi.2018.12.008.
78. Palaiokostas C, Robledo D, Vesely T, Prchal M, Pokorova D, Piackova V, et al.
Mapping and sequencing of a significant quantitative trait locus affecting
resistance to koi Herpesvirus in common carp. G3 Genes Genomes Genet.
2018;8:3507–13.
79. Mjaaland S, Rimstad E, Falk K, Dannevig BH. Genomic characterization of the
virus causing infectious salmon anemia in Atlantic salmon (Salmo salar L.):
an orthomyxo-like virus in a teleost. J Virol. 1997;71(10):7681–6. https://doi.
org/10.1128/JVI.71.10.7681-7686.1997.
80. Gilmour AR, Gobel BJ, Cullis BR, Thompson R. ASReml user guide release 3.0.
Hemel Hempstead, HP1 1ES. Hemel Hempstead: VSN International Ltd;
2009.
81. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al.
PLINK: a tool set for whole-genome association and population-based
Gervais et al. BMC Genomics          (2021) 22:345 Page 13 of 14
linkage analyses. Am J Hum Genet. 2007;81(3):559–75. https://doi.org/10.1
086/519795.
82. Wang H, Misztal I, Aguilar I, Legarra A, Muir WM. Genome-wide association
mapping including phenotypes from relatives without genotypes. Genet
Res. 2012;94(2):73–83. https://doi.org/10.1017/S0016672312000274.
83. Aguilar I, Misztal I, Johnson DL, Legarra A, Tsuruta S, Lawlor TJ. Hot topic: a
unified approach to utilize phenotypic, full pedigree, and genomic
information for genetic evaluation of Holstein final score. J Dairy Sci. 2010;
93(2):743–52. https://doi.org/10.3168/jds.2009-2730.
84. Wang H, Misztal I, Aguilar I, Legarra A, Fernando RL, Vitezica Z, et al.
Genome-wide association mapping including phenotypes from relatives
without genotypes in a single-step (ssGWAS) for 6-week body weight in
broiler chickens. Front Genet. 2014;5:134.
85. Misztal I, Lourenco D, Aguilar I, Legarra A, Vitezica Z. Manual for BLUPF90
family of programs; 2016. p. 125.
86. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide
complex trait analysis. Am J Hum Genet. 2011;88(1):76–82. https://doi.org/1
0.1016/j.ajhg.2010.11.011.
87. Lien S, Koop BF, Sandve SR, Miller JR, Kent MP, Nome T, et al. The Atlantic
salmon genome provides insights into rediploidization. Nature. 2016;
533(7602):200–5. https://doi.org/10.1038/nature17164.
88. Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-
seq quantification. Nat Biotechnol. 2016;34(5):525–7. https://doi.org/10.1038/
nbt.3519.
89. R Core Team. R: a language and environment for statistical computing.
Vienna: R Foundation for statistical Computing; 2020. https://www.R-project.
org
90. Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq:
transcript-level estimates improve gene-level inferences. F1000Research.
2016;4:1521.
91. Love MI, Huber W, Anders S. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
https://doi.org/10.1186/s13059-014-0550-8.
92. Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S, et al. KOBAS 2.0: a web server
for annotation and identification of enriched pathways and diseases.
Nucleic Acids Res. 2011;39(Web Server issue):W316–22.
93. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 2000;28(1):27–30. https://doi.org/10.1093/nar/28.1.27.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Gervais et al. BMC Genomics          (2021) 22:345 Page 14 of 14
